Cargando…
Donor-Derived Cell-Free DNA in Kidney Transplantation: Origins, Present and a Look to the Future
Since its first detection in 1948, donor-derived cell-free DNA (dd-cfDNA) has been employed for a myriad of indications in various medical specialties. It has had a far-reaching impact in solid organ transplantation, with the most widespread utilization in kidney transplantation for the surveillance...
Autores principales: | Kant, Sam, Brennan, Daniel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151129/ https://www.ncbi.nlm.nih.gov/pubmed/34065914 http://dx.doi.org/10.3390/medicina57050482 |
Ejemplares similares
-
Donor Derived Cell Free DNA in Kidney Transplantation: The Circa 2020–2021 Update
por: Kant, Sam, et al.
Publicado: (2022) -
Donor-derived Cell-free DNA and the Prediction of BK Virus-associated Nephropathy
por: Kant, Sam, et al.
Publicado: (2020) -
Donor-derived Cell-free DNA Kinetics Post-kidney Transplant Biopsy
por: Kyeso, Yousuf, et al.
Publicado: (2021) -
Utility of Donor-Derived Cell-Free DNA in Detecting ABMR in Patients With AT1R Antibodies
por: Kant, Sam, et al.
Publicado: (2021) -
Donor-derived Cell-free DNA in Infections in Kidney Transplant Recipients: Case Series
por: Goussous, Naeem, et al.
Publicado: (2020)